| abstract |
A solid pharmaceutical form for use in the treatment of a patient with HIV, wherein the treatment consists in administering to said patient said solid dosage form, where the patient takes the pharmaceutical form independently of whether the patient has ingested, or not, food, where Said pharmaceutical form contains a solid solution or a solid dispersion of lopinavir in at least one water-soluble pharmaceutically acceptable polymer with a Tg of at least 50 ° C and at least one pharmaceutically acceptable nonionic surfactant. |